ATS 2018 International Conference - Mobile

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease (Study RIN-PH-201) [Board No. P179]

Location: Board no. P179

Session Type: Thematic Poster Session

Tuesday

May

22

11:15 AM

1:00 PM

Speaker(s)/Author(s)

Peter M. Smith

Pharm D
United Therapeutics

Chunqin Deng

MD, PhD
United Therapeutics

Steven Nathan

MD
Inova;Inova Fairfax Hosp;Inova Fairfax Hospital;Inova Heart and Vascular Institute, Inova Fairfax Hospital

Victor F. Tapson

MD
Cedars Sinai;Cedars-Sinai;Cedars-Sinai Medical Center

Aaron B. Waxman

MD, PhD
Brigham and Woman's Hosp

View Abstract

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects with Pulmonary Hypertension Due to Parenchymal Lung Disease (Study RIN-PH-201)

Parent Sessions

C69 - USE YOUR ILLUSION: NOVEL THERAPEUTIC APPROACHES IN PULMONARY HYPERTENSION...
05-22-2018 9:15 AM - 4:15 PM